Excimer and Femtosecond Ophthalmic Lasers Market to Surpass US$ 2.41 Bn by 2032 attributing to improved exposure to Eye Care Services | Future Market Insights, Inc.
11 oct. 2022 09h00 HE
|
Future Market Insights Global and Consulting Pvt. Ltd.
NEWARK, Del: , Oct. 11, 2022 (GLOBE NEWSWIRE) -- The global excimer and femtosecond ophthalmic lasers market is projected to rise at a robust pace of 8.0% CAGR over the assessment years from 2022 to...
Global Diabetic Retinopathy Market Size To Reach USD 103.2 BN By 2030 | CAGR 16.7%; Spherical Insights & Consulting
29 sept. 2022 05h50 HE
|
SPHERICAL INSIGHTS LLP
New York, USA, Sept. 29, 2022 (GLOBE NEWSWIRE) -- The Global Diabetic Retinopathy Market Size Was USD 3.8 Billion In 2020 And Is Projected To Reach USD 103.2 Billion By 2030, Grow A CAGR Of 16.7%....
Anti-VEGF Market Size is projected to reach USD 13.54 Billion by 2030, growing at a CAGR of 1.02%: Straits Research
21 juil. 2022 16h00 HE
|
Straits Research
New York, United States, July 21, 2022 (GLOBE NEWSWIRE) -- Vascular endothelial Growth factor, also known as VEGF, is a naturally occurring protein in the human body responsible for forming and...
UK National Screening Committee Report Singles Out Eyenuk’s EyeArt as the Only Diabetic Eye Screening AI Technology Ready for Live Clinical Implementation in the National Health Service
01 juin 2022 03h05 HE
|
Eyenuk, Inc.
LOS ANGELES, June 01, 2022 (GLOBE NEWSWIRE) -- Eyenuk, Inc., a global artificial intelligence (AI) medical technology and services company and the leader in real-world applications for AI Eye...
Diabetic Retinopathy Pipeline Insights | Clinical Trials Evaluation Report 2022 by DelveInsight
30 mai 2022 13h00 HE
|
DelveInsight Business Research LLP
Las Vegas, USA, May 30, 2022 (GLOBE NEWSWIRE) -- Diabetic Retinopathy Pipeline Insights | Clinical Trials Evaluation Report 2022 by DelveInsight Diabetic Retinopathy Pipeline involves 80+ key...
Eyenuk Joins the Population Health Alliance, Paving Way for Autonomous AI to Improve Diabetes Complications
10 mars 2022 08h00 HE
|
Eyenuk, Inc.
WASHINGTON, March 10, 2022 (GLOBE NEWSWIRE) -- Population Health Alliance (PHA), the industry’s only multi-stakeholder professional and trade association solely focused on population health,...
Eyenuk Announces Publication of Strong EyeArt® Pivotal Clinical Trial Results in JAMA Network Open
15 nov. 2021 14h38 HE
|
Eyenuk, Inc.
LOS ANGELES, Nov. 15, 2021 (GLOBE NEWSWIRE) -- Eyenuk, Inc., a global artificial intelligence (AI) medical technology and services company and the leader in real-world applications for AI Eye...
Eyenuk Applauds CMS CY 2022 Medicare Physician Fee Schedule Final Rule to Establish National Price for Autonomous AI Technology
04 nov. 2021 17h09 HE
|
Eyenuk, Inc.
LOS ANGELES, Nov. 04, 2021 (GLOBE NEWSWIRE) -- Eyenuk, Inc., a global artificial intelligence (AI) medical technology and services company and the leader in real-world applications for AI Eye...
Eyenuk Reports Strong 2021 Business Growth
12 mai 2021 11h00 HE
|
Eyenuk, Inc.
LOS ANGELES, May 12, 2021 (GLOBE NEWSWIRE) -- Eyenuk, Inc., a global artificial intelligence (AI) medical technology and services company and the leader in real-world applications for AI Eye...
National Coalition Launches new scEYEnce Campaign
09 sept. 2020 09h00 HE
|
scEYEnce
—Effort points to the vital importance of vision research, how it is improving sight and broader health and well-being—NEW YORK, Sept. 09, 2020 (GLOBE NEWSWIRE) -- A national coalition of 10 leading...